A prospective study of the detection and monitoring of circulating tumor cells in patients with operable breast cancer

A prospective study of the detection and monitoring of circulating tumor cells in patients with operable breast cancer - Circulating tumor cells in peripheral and drainage vein blood of operable breast cancer patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000028434

Enrollment

Registered

2017-07-31

Start date

2016-10-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Operable breast cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with more than 20 years. 2) Patients who undergo breast surgery with axillary lymph node dissection for breast cancer determined by histological or cytological diagnosis. 3) Patients providing written informed consent.

Exclusion criteria

Exclusion criteria: 1) Patient with other active cancer (except cancer treated without recurrence in more than 5 years and after carcinoma complete excision in situ) 2) Any other patients who are regarded as unsuitable for this study by the investigators.

Design outcomes

Primary

Measure	Time frame
Distribution of CTC in periferal and tumor drainage venous blood. Clinical utility of CTC as a biomarker for monitoring of disease status.	—

Secondary

Measure	Time frame
Assessment of the molecular characteristics of CTC. Association between the amount of CTC and clinical course.	—

Countries

Japan

Contacts

Public ContactMasaya Hattori

Aichi Cancer Center Hospital Department of Breast Oncology

mhattori@aichi-cc.jp0527626111

Outcome results